Loading…
Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice
Objective: For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to perip...
Saved in:
Published in: | European journal of cardio-thoracic surgery 2006-08, Vol.30 (2), p.362-369 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c460t-53d57efa3b608a96bbee5c532ae1335f8293295e394386695e856db02730c4ca3 |
---|---|
cites | |
container_end_page | 369 |
container_issue | 2 |
container_start_page | 362 |
container_title | European journal of cardio-thoracic surgery |
container_volume | 30 |
creator | Stremmel, Christian Sienel, Wulf Eggeling, Stephan Passlick, Bernward Slavin, Anthony |
description | Objective: For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to peripheral lymph nodes. Maybe the preventing of T cell homing will change the immune response against allogeneic tissue and suppress rejection. Methods: We treated different mouse strains with pertussis toxin to manipulate T cell homing and measured the rejection of allografts in terms of allogeneic tumor cells. We transferred pertussis toxin treated or nontreated transgenic T cells into BALB/c wild type mice. The transgenic T cells could be followed ex vivo by specific antibodies. Cytokine production from purified (1 × 105/ml) T cells after different stimulations in vitro and expression of surface markers on T cells following pertussis toxin treatment by FACS analysis were performed. Results: Pertussis toxin-treated C57BL/6 mice with the MHC class I molecule H-2Kb could not reject allogeneic tumor cells R1.1, which expressed the MHC class I molecule H-2Kk and were killed by these cells. This allograft survival could be demonstrated for various allogeneic cells in different mouse strains with different MHC class I expression and emphasizes the general mechanism in these studies. In vivo CD62L expression on T cells was down-regulated by pertussis toxin in normal mice and transgenic mice that produce only one specific T cell, and after the pertussis toxin treatment the mice showed 4–5 times larger spleens compared to untreated mice. In transfer experiments, we demonstrated that CD62L low transgenic T cells could not home to lymph nodes. Furthermore, spleen cells from pertussis toxin-treated mice produced high amounts of the Th-2 cytokine interleukin 4 after stimulation in primary culture. Conclusions: Our data suggest that the inhibition of T cell homing changes the immune response. Prevention of homing of T cells in combination with the induction of a Th-2 response is a mechanism to prevent specific acute rejection of allogeneic tissue. |
doi_str_mv | 10.1016/j.ejcts.2006.04.014 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68672632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/j.ejcts.2006.04.014</oup_id><sourcerecordid>68672632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-53d57efa3b608a96bbee5c532ae1335f8293295e394386695e856db02730c4ca3</originalsourceid><addsrcrecordid>eNqNkU-PlTAUxYnROOPoJzAxXbkDS1sKLA3-mUle4gaTyWyaUi6PIrTYltH5IH5f--SNbl31pvd3TnLPSZLXOc5ynPN3UwaTCj4jGPMMswzn7ElymVclTUvKbp_GGec4LWuGL5IX3k84gpSUz5OLnFekKji7TH7dmFF3OmhrkB1QixTMMxrtos0RdQ-otz9M6uC4zfKRaT5wckDS9CiMgLTpN_W4kqgdU4Ic-NUaD0j6-LVAGG2ELVod3IMJSKotxOU826OTQ4j8BLuHNmjRCl4mzwY5e3h1fq-Sr58-ts11evjy-aZ5f0gV4zikBe2LEgZJO44rWfOuAyhUQYmEnNJiqEhNSV0ArRmtOI9TPLrvMCkpVkxJepW83X1XZ79v4INYtD8lIA3YzQte8ZLEzCJId1A5672DQaxOL9I9iByLUxtiEn_aEKc2BGYithFVb872W7dA_09zjj8C2Q7Ybf1Px3QXaB_g51-JdN8EL2lZiOvbO9FWbYPvcCMY_Q3dlqWq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68672632</pqid></control><display><type>article</type><title>Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice</title><source>Oxford Journals Online</source><creator>Stremmel, Christian ; Sienel, Wulf ; Eggeling, Stephan ; Passlick, Bernward ; Slavin, Anthony</creator><creatorcontrib>Stremmel, Christian ; Sienel, Wulf ; Eggeling, Stephan ; Passlick, Bernward ; Slavin, Anthony</creatorcontrib><description>Objective: For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to peripheral lymph nodes. Maybe the preventing of T cell homing will change the immune response against allogeneic tissue and suppress rejection. Methods: We treated different mouse strains with pertussis toxin to manipulate T cell homing and measured the rejection of allografts in terms of allogeneic tumor cells. We transferred pertussis toxin treated or nontreated transgenic T cells into BALB/c wild type mice. The transgenic T cells could be followed ex vivo by specific antibodies. Cytokine production from purified (1 × 105/ml) T cells after different stimulations in vitro and expression of surface markers on T cells following pertussis toxin treatment by FACS analysis were performed. Results: Pertussis toxin-treated C57BL/6 mice with the MHC class I molecule H-2Kb could not reject allogeneic tumor cells R1.1, which expressed the MHC class I molecule H-2Kk and were killed by these cells. This allograft survival could be demonstrated for various allogeneic cells in different mouse strains with different MHC class I expression and emphasizes the general mechanism in these studies. In vivo CD62L expression on T cells was down-regulated by pertussis toxin in normal mice and transgenic mice that produce only one specific T cell, and after the pertussis toxin treatment the mice showed 4–5 times larger spleens compared to untreated mice. In transfer experiments, we demonstrated that CD62L low transgenic T cells could not home to lymph nodes. Furthermore, spleen cells from pertussis toxin-treated mice produced high amounts of the Th-2 cytokine interleukin 4 after stimulation in primary culture. Conclusions: Our data suggest that the inhibition of T cell homing changes the immune response. Prevention of homing of T cells in combination with the induction of a Th-2 response is a mechanism to prevent specific acute rejection of allogeneic tissue.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/j.ejcts.2006.04.014</identifier><identifier>PMID: 16828564</identifier><language>eng</language><publisher>Germany: Elsevier Science B.V</publisher><subject>Acute Disease ; Adoptive Transfer ; Allograft rejection ; Animals ; CD62L ; Cell Movement - immunology ; Cell Proliferation ; Cells, Cultured ; Cytokines - biosynthesis ; Down-Regulation - immunology ; Female ; Graft Rejection - immunology ; Graft Rejection - prevention & control ; Homing ; Immune Tolerance ; L-Selectin - immunology ; L-Selectin - metabolism ; Lymphocyte Activation - immunology ; Mice ; Mice, Inbred Strains ; Neoplasm Transplantation ; Pertussis Toxin - immunology ; Th2 Cells - immunology ; Transplantation ; Tumor Cells, Cultured</subject><ispartof>European journal of cardio-thoracic surgery, 2006-08, Vol.30 (2), p.362-369</ispartof><rights>2006 Elsevier B.V. All rights reserved. 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-53d57efa3b608a96bbee5c532ae1335f8293295e394386695e856db02730c4ca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16828564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stremmel, Christian</creatorcontrib><creatorcontrib>Sienel, Wulf</creatorcontrib><creatorcontrib>Eggeling, Stephan</creatorcontrib><creatorcontrib>Passlick, Bernward</creatorcontrib><creatorcontrib>Slavin, Anthony</creatorcontrib><title>Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>Objective: For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to peripheral lymph nodes. Maybe the preventing of T cell homing will change the immune response against allogeneic tissue and suppress rejection. Methods: We treated different mouse strains with pertussis toxin to manipulate T cell homing and measured the rejection of allografts in terms of allogeneic tumor cells. We transferred pertussis toxin treated or nontreated transgenic T cells into BALB/c wild type mice. The transgenic T cells could be followed ex vivo by specific antibodies. Cytokine production from purified (1 × 105/ml) T cells after different stimulations in vitro and expression of surface markers on T cells following pertussis toxin treatment by FACS analysis were performed. Results: Pertussis toxin-treated C57BL/6 mice with the MHC class I molecule H-2Kb could not reject allogeneic tumor cells R1.1, which expressed the MHC class I molecule H-2Kk and were killed by these cells. This allograft survival could be demonstrated for various allogeneic cells in different mouse strains with different MHC class I expression and emphasizes the general mechanism in these studies. In vivo CD62L expression on T cells was down-regulated by pertussis toxin in normal mice and transgenic mice that produce only one specific T cell, and after the pertussis toxin treatment the mice showed 4–5 times larger spleens compared to untreated mice. In transfer experiments, we demonstrated that CD62L low transgenic T cells could not home to lymph nodes. Furthermore, spleen cells from pertussis toxin-treated mice produced high amounts of the Th-2 cytokine interleukin 4 after stimulation in primary culture. Conclusions: Our data suggest that the inhibition of T cell homing changes the immune response. Prevention of homing of T cells in combination with the induction of a Th-2 response is a mechanism to prevent specific acute rejection of allogeneic tissue.</description><subject>Acute Disease</subject><subject>Adoptive Transfer</subject><subject>Allograft rejection</subject><subject>Animals</subject><subject>CD62L</subject><subject>Cell Movement - immunology</subject><subject>Cell Proliferation</subject><subject>Cells, Cultured</subject><subject>Cytokines - biosynthesis</subject><subject>Down-Regulation - immunology</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Rejection - prevention & control</subject><subject>Homing</subject><subject>Immune Tolerance</subject><subject>L-Selectin - immunology</subject><subject>L-Selectin - metabolism</subject><subject>Lymphocyte Activation - immunology</subject><subject>Mice</subject><subject>Mice, Inbred Strains</subject><subject>Neoplasm Transplantation</subject><subject>Pertussis Toxin - immunology</subject><subject>Th2 Cells - immunology</subject><subject>Transplantation</subject><subject>Tumor Cells, Cultured</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkU-PlTAUxYnROOPoJzAxXbkDS1sKLA3-mUle4gaTyWyaUi6PIrTYltH5IH5f--SNbl31pvd3TnLPSZLXOc5ynPN3UwaTCj4jGPMMswzn7ElymVclTUvKbp_GGec4LWuGL5IX3k84gpSUz5OLnFekKji7TH7dmFF3OmhrkB1QixTMMxrtos0RdQ-otz9M6uC4zfKRaT5wckDS9CiMgLTpN_W4kqgdU4Ic-NUaD0j6-LVAGG2ELVod3IMJSKotxOU826OTQ4j8BLuHNmjRCl4mzwY5e3h1fq-Sr58-ts11evjy-aZ5f0gV4zikBe2LEgZJO44rWfOuAyhUQYmEnNJiqEhNSV0ArRmtOI9TPLrvMCkpVkxJepW83X1XZ79v4INYtD8lIA3YzQte8ZLEzCJId1A5672DQaxOL9I9iByLUxtiEn_aEKc2BGYithFVb872W7dA_09zjj8C2Q7Ybf1Px3QXaB_g51-JdN8EL2lZiOvbO9FWbYPvcCMY_Q3dlqWq</recordid><startdate>200608</startdate><enddate>200608</enddate><creator>Stremmel, Christian</creator><creator>Sienel, Wulf</creator><creator>Eggeling, Stephan</creator><creator>Passlick, Bernward</creator><creator>Slavin, Anthony</creator><general>Elsevier Science B.V</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200608</creationdate><title>Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice</title><author>Stremmel, Christian ; Sienel, Wulf ; Eggeling, Stephan ; Passlick, Bernward ; Slavin, Anthony</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-53d57efa3b608a96bbee5c532ae1335f8293295e394386695e856db02730c4ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Acute Disease</topic><topic>Adoptive Transfer</topic><topic>Allograft rejection</topic><topic>Animals</topic><topic>CD62L</topic><topic>Cell Movement - immunology</topic><topic>Cell Proliferation</topic><topic>Cells, Cultured</topic><topic>Cytokines - biosynthesis</topic><topic>Down-Regulation - immunology</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Rejection - prevention & control</topic><topic>Homing</topic><topic>Immune Tolerance</topic><topic>L-Selectin - immunology</topic><topic>L-Selectin - metabolism</topic><topic>Lymphocyte Activation - immunology</topic><topic>Mice</topic><topic>Mice, Inbred Strains</topic><topic>Neoplasm Transplantation</topic><topic>Pertussis Toxin - immunology</topic><topic>Th2 Cells - immunology</topic><topic>Transplantation</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stremmel, Christian</creatorcontrib><creatorcontrib>Sienel, Wulf</creatorcontrib><creatorcontrib>Eggeling, Stephan</creatorcontrib><creatorcontrib>Passlick, Bernward</creatorcontrib><creatorcontrib>Slavin, Anthony</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stremmel, Christian</au><au>Sienel, Wulf</au><au>Eggeling, Stephan</au><au>Passlick, Bernward</au><au>Slavin, Anthony</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>2006-08</date><risdate>2006</risdate><volume>30</volume><issue>2</issue><spage>362</spage><epage>369</epage><pages>362-369</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><abstract>Objective: For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to peripheral lymph nodes. Maybe the preventing of T cell homing will change the immune response against allogeneic tissue and suppress rejection. Methods: We treated different mouse strains with pertussis toxin to manipulate T cell homing and measured the rejection of allografts in terms of allogeneic tumor cells. We transferred pertussis toxin treated or nontreated transgenic T cells into BALB/c wild type mice. The transgenic T cells could be followed ex vivo by specific antibodies. Cytokine production from purified (1 × 105/ml) T cells after different stimulations in vitro and expression of surface markers on T cells following pertussis toxin treatment by FACS analysis were performed. Results: Pertussis toxin-treated C57BL/6 mice with the MHC class I molecule H-2Kb could not reject allogeneic tumor cells R1.1, which expressed the MHC class I molecule H-2Kk and were killed by these cells. This allograft survival could be demonstrated for various allogeneic cells in different mouse strains with different MHC class I expression and emphasizes the general mechanism in these studies. In vivo CD62L expression on T cells was down-regulated by pertussis toxin in normal mice and transgenic mice that produce only one specific T cell, and after the pertussis toxin treatment the mice showed 4–5 times larger spleens compared to untreated mice. In transfer experiments, we demonstrated that CD62L low transgenic T cells could not home to lymph nodes. Furthermore, spleen cells from pertussis toxin-treated mice produced high amounts of the Th-2 cytokine interleukin 4 after stimulation in primary culture. Conclusions: Our data suggest that the inhibition of T cell homing changes the immune response. Prevention of homing of T cells in combination with the induction of a Th-2 response is a mechanism to prevent specific acute rejection of allogeneic tissue.</abstract><cop>Germany</cop><pub>Elsevier Science B.V</pub><pmid>16828564</pmid><doi>10.1016/j.ejcts.2006.04.014</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1010-7940 |
ispartof | European journal of cardio-thoracic surgery, 2006-08, Vol.30 (2), p.362-369 |
issn | 1010-7940 1873-734X |
language | eng |
recordid | cdi_proquest_miscellaneous_68672632 |
source | Oxford Journals Online |
subjects | Acute Disease Adoptive Transfer Allograft rejection Animals CD62L Cell Movement - immunology Cell Proliferation Cells, Cultured Cytokines - biosynthesis Down-Regulation - immunology Female Graft Rejection - immunology Graft Rejection - prevention & control Homing Immune Tolerance L-Selectin - immunology L-Selectin - metabolism Lymphocyte Activation - immunology Mice Mice, Inbred Strains Neoplasm Transplantation Pertussis Toxin - immunology Th2 Cells - immunology Transplantation Tumor Cells, Cultured |
title | Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A49%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20T%20cell%20homing%20by%20down-regulation%20of%20CD62L%20and%20the%20induction%20of%20a%20Th-2%20response%20as%20a%20method%20to%20prevent%20acute%20allograft%20rejection%20in%20mice&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Stremmel,%20Christian&rft.date=2006-08&rft.volume=30&rft.issue=2&rft.spage=362&rft.epage=369&rft.pages=362-369&rft.issn=1010-7940&rft.eissn=1873-734X&rft_id=info:doi/10.1016/j.ejcts.2006.04.014&rft_dat=%3Cproquest_cross%3E68672632%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c460t-53d57efa3b608a96bbee5c532ae1335f8293295e394386695e856db02730c4ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68672632&rft_id=info:pmid/16828564&rft_oup_id=10.1016/j.ejcts.2006.04.014&rfr_iscdi=true |